Challenges of Mood Disorders Care.
出版信息
Focus (Am Psychiatr Publ). 2020 Apr;18(2):205-207. doi: 10.1176/appi.focus.18202. Epub 2020 Apr 23.
Abstract
摘要
相似文献
1
Challenges of Mood Disorders Care.
Focus (Am Psychiatr Publ). 2020 Apr;18(2):205-207. doi: 10.1176/appi.focus.18202. Epub 2020 Apr 23.
2
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383.
3
Sex differences in mood disorders: perspectives from humans and rodent models.
Biol Sex Differ. 2014 Dec 7;5(1):17. doi: 10.1186/s13293-014-0017-3. eCollection 2014.
4
Challenges in conceptualizing psychotic mood disorders.
Bull Menninger Clin. 1994 Spring;58(2):197-214.
5
Immune-based strategies for mood disorders: facts and challenges.
Expert Rev Neurother. 2018 Feb;18(2):139-152. doi: 10.1080/14737175.2018.1407242. Epub 2017 Nov 27.
6
Undiagnosed mood disorders and sleep disturbances in primary care patients with chronic musculoskeletal pain.
Pain Med. 2013 Sep;14(9):1416-25. doi: 10.1111/pme.12165. Epub 2013 Jun 6.
7
Direct incremental healthcare costs associated with mood disorders in the United States, 2007-2017.
J Affect Disord. 2020 Aug 1;273:304-309. doi: 10.1016/j.jad.2020.03.127. Epub 2020 Apr 30.
8
Unmet needs and research challenges for late-life mood disorders.
Aging Clin Exp Res. 2014 Apr;26(2):101-14. doi: 10.1007/s40520-013-0149-z.
9
Anxiety and mood disorders in primary care practice.
Int J Psychiatry Clin Pract. 2004;8(2):77-84. doi: 10.1080/13651500310004966.
10
Mood disorders associated with interferon treatment: theoretical and practical considerations.
Ann Pharmacother. 2001 Apr;35(4):489-95. doi: 10.1345/aph.10172.
本文引用的文献
1
Pharmacological interventions for treatment-resistant depression in adults.
Cochrane Database Syst Rev. 2019 Dec 17;12(12):CD010557. doi: 10.1002/14651858.CD010557.pub2.
2
Reconciling Suicides With "Accidental" Drug-Intoxication Deaths: A Behaviorally Based Definition of Self-Injury Mortality.
Am J Public Health. 2020 Jan;110(1):73-74. doi: 10.2105/AJPH.2019.305422.
3
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3.
Am J Geriatr Psychiatry. 2020 Feb;28(2):121-141. doi: 10.1016/j.jagp.2019.10.008. Epub 2019 Oct 17.
4
Clinical or gimmickal: The use and effectiveness of mobile mental health apps for treating anxiety and depression.
Aust N Z J Psychiatry. 2020 Jan;54(1):20-28. doi: 10.1177/0004867419876700. Epub 2019 Sep 25.
5
Treatments for the Prevention and Management of Suicide: A Systematic Review.
Ann Intern Med. 2019 Sep 3;171(5):334-342. doi: 10.7326/M19-0869. Epub 2019 Aug 27.
6
A Key Differential Diagnosis for Physicians-Major Depression or Burnout?
JAMA Psychiatry. 2019 Nov 1;76(11):1111-1112. doi: 10.1001/jamapsychiatry.2019.1332.
7
Working With Patients Who Self-injure.
JAMA Psychiatry. 2019 Sep 1;76(9):976-977. doi: 10.1001/jamapsychiatry.2019.1241.
8
Computer-Assisted Cognitive-Behavior Therapy and Mobile Apps for Depression and Anxiety.
Curr Psychiatry Rep. 2019 Jun 27;21(7):62. doi: 10.1007/s11920-019-1031-2.
9
Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.
Lancet Psychiatry. 2019 Jul;6(7):601-609. doi: 10.1016/S2215-0366(19)30217-2. Epub 2019 Jun 6.
10
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Am J Psychiatry. 2019 Jun 1;176(6):428-438. doi: 10.1176/appi.ajp.2019.19020172. Epub 2019 May 21.
Zotero 插件